Finance

Beta
Lists
07X:FRA
Annovis Bio Inc
€1.56
-2.86%
(-0.046) 1D
Jun 16, 3:00:52 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 07X...
Open
€1.52
High
€1.56
Low
€1.52
Mkt. cap
62.19M
Avg. vol.
1.89K
Volume
600.00
52-wk high
€4.61
52-wk low
€1.35
No. of employees
8
Open
€1.52
High
€1.56
Low
€1.52
Mkt. cap
62.19M
Avg. vol.
1.89K
Volume
600.00
52-wk high
€4.61
52-wk low
€1.35
No. of employees
8
News stories
From sources across the web
About Annovis Bio Inc
CEOMaria-luisa Maccecchini
Employees8
Founded2008
HeadquartersMalvern, Pennsylvania, United States
SectorBiotechnology
Websiteannovisbio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.01M
5.16M
6.29M
8.75M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.27M
1.11M
1.14M
955.15K
Operating expense
6.28M
6.27M
7.43M
9.71M
Total operating expenses
6.28M
6.27M
7.43M
9.71M
Operating income
-6.28M
-6.27M
-7.43M
-9.71M
Other non operating income
558.00K
-140.00K
20.00K
-296.00K
EBT including unusual items
-5.54M
-6.22M
-7.26M
-9.83M
EBT excluding unusual items
-5.54M
-6.22M
-7.26M
-9.83M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.54M
-6.22M
-7.26M
-9.83M
Net profit margin
-
-
-
-
Earnings per share
-0.32
-0.32
-0.37
-0.39
Interest and investment income
187.61K
191.40K
152.32K
167.74K
Interest expense
-
-
-
-
Net interest expenses
187.61K
191.40K
152.32K
167.74K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer